MedTrace Logo

Pulpotomy in Primary Molars Treated With Premixed Bio-ceramic MTA Versus Formocresol

NCT05314842 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-04-06

No results posted yet for this study

Summary

examine the results of pulpotomy in primary molars using premixed bioceramic MTA versus Formocresol. Clinical and radiographic success rates were used as outcomes.

Conditions

  • Caries

Interventions

DRUG

Formocresol

dressing agents in pulpotomized primary molas using formocresol in cariously exposed vital primary molars

DRUG

Premixed bioceramic MTA

dressing agents in pulpotomized primary molas using premixed bioceramic MTA in cariously exposed vital primary molars

Sponsors & Collaborators

  • Sarah Abdelbar Mahmoud

    lead OTHER

Principal Investigators

  • ahmed m Elkhadem, Ass.Prof · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2023-04-01
Completion
2023-05-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05314842 on ClinicalTrials.gov